JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265179

Human MRPS7 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MRPS7 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 1 and 2 bp deletion in exon 1 and 31 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
3 Images
Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)
  • Sanger seq

Unknown

Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)

Allele-1 : 31 bp deletion in exon 1.

Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)
  • Sanger seq

Unknown

Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)

Allele-2 : 11 bp deletion in exon 1.

Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)
  • Sanger seq

Unknown

Sanger Sequencing - Human MRPS7 knockout HeLa cell line (AB265179)

Allele-3 : 2 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 1 and 2 bp deletion in exon 1 and 31 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265179-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265179-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265179 Human MRPS7 knockout HeLa cell line", "number":"AB265179-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265179-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265179-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265179 Human MRPS7 knockout HeLa cell line", "number":"AB265179-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265179-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265179 Human MRPS7 knockout HeLa cell line", "number":"AB265179-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265179-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265179 Human MRPS7 knockout HeLa cell line", "number":"AB265179-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MRPS7
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The MRPS7 protein also known as mitochondrial ribosomal protein S7 plays a major role in protein synthesis within mitochondria. The mass of MRPS7 is approximately 20 kDa. The protein is expressed within the mitochondria of cells. It is a component of the small 28S subunit of the mitochondrial ribosome which is distinct from the cytoplasmic ribosomes. MRPS7 is an essential part of the ribosome's machinery ensuring the accurate translation of mitochondrial genes into functional proteins.
Biological function summary

MRPS7 is involved in mitochondrial translation a process critical for cellular respiration and energy production. This protein is part of the mitochondrial ribosomal complex which includes both proteins and rRNA. By playing an active role in assembling and stabilizing the ribosome MRPS7 helps in translating mRNA transcribed from mitochondrial DNA. This translation is necessary for the production of essential components of the electron transport chain which generates ATP.

Pathways

MRPS7 engages in the mitochondrial translation pathway which ensures the synthesis of proteins required for the oxidative phosphorylation pathway. It interacts with other mitochondrial ribosomal proteins like MRPS28 to form a functional ribosome. Through these interactions MRPS7 helps maintain the efficiency and fidelity of mitochondrial protein synthesis directly affecting cellular energy metabolism and homeostasis.

Research has associated defects in MRPS7 with disorders involving mitochondrial dysfunction such as mitochondrial myopathy. This condition impacts muscle function due to impaired energy production in the mitochondria. MRPS7 mutations may also relate to neurological disorders where mitochondrial performance is compromised. Such conditions often involve other mitochondrial ribosomal proteins like MRPL3 indicating a network of protein interactions necessary for mitochondrial integrity and function.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com